Yatharth Hospital & Trauma Care Services Ltd
NSE:YATHARTH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
358.85
831.85
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Yatharth Hospital & Trauma Care Services Ltd
Yatharth Hospital & Trauma Care Services Ltd is a IN-based company operating in Health Care Providers & Services industry. The company is headquartered in Greater Noida, Uttar Pradesh. The company went IPO on 2023-08-07. Yatharth Hospital & Trauma Care Services Limited is engaged in the business of providing healthcare services, operating hospitals, and other allied services. The company offers facilities, such as amenities, guidelines for admission, visitor policy, helpdesk, and empanelment. The firm provides a spectrum of super specialty services in the field of cardiology, cardiovascular and thoracic surgery, neurology, neurosurgery, urology, nephrology, oncology, gastroenterology and surgical gastroenterology, orthopedics, including spine surgery, joint replacement, and sports medicine, plastic and reconstructive surgery, pulmonology, comprehensive mother and childcare including advanced in vitro fertilization. The firm also provides services, such as dermatology, ophthalmology, dentistry, psychology and psychiatry, anesthesiology, physiotherapy and rehab, radiology, pathology and laboratory medicine, and nutrition and health. The company has hospitals in Noida, Jhansi, Greater Noida, and Noida Extension.
Yatharth Hospital & Trauma Care Services Ltd is a IN-based company operating in Health Care Providers & Services industry. The company is headquartered in Greater Noida, Uttar Pradesh. The company went IPO on 2023-08-07. Yatharth Hospital & Trauma Care Services Limited is engaged in the business of providing healthcare services, operating hospitals, and other allied services. The company offers facilities, such as amenities, guidelines for admission, visitor policy, helpdesk, and empanelment. The firm provides a spectrum of super specialty services in the field of cardiology, cardiovascular and thoracic surgery, neurology, neurosurgery, urology, nephrology, oncology, gastroenterology and surgical gastroenterology, orthopedics, including spine surgery, joint replacement, and sports medicine, plastic and reconstructive surgery, pulmonology, comprehensive mother and childcare including advanced in vitro fertilization. The firm also provides services, such as dermatology, ophthalmology, dentistry, psychology and psychiatry, anesthesiology, physiotherapy and rehab, radiology, pathology and laboratory medicine, and nutrition and health. The company has hospitals in Noida, Jhansi, Greater Noida, and Noida Extension.
Record Revenue and EBITDA: Yatharth Hospital delivered its highest-ever quarterly revenue and EBITDA, with revenue reaching INR 2,794 million, up 28% year-over-year and 8% quarter-over-quarter.
Expansion Momentum: The company added 700 beds by operationalizing new hospitals in Delhi and Faridabad, and acquired a running hospital in Agra, further fueling growth.
Profitability Resilience: Despite initial losses from new hospitals, adjusted EBITDA grew by 35% year-over-year, and margins are expected to improve as new capacities ramp up.
Strong Balance Sheet: Yatharth remains debt-free with a net cash position of INR 3,692 million, supporting ongoing and future expansion plans.
Guidance Upbeat: Management is confident of exceeding 30% revenue growth for the year, maintaining or improving margins, and achieving EBITDA breakeven at new hospitals within 15-17 months.
CGHS Rate Revision Benefit: The recent central government health scheme rate revision is expected to boost overall revenue by at least 2.5% next year, with a positive impact on profitability.
ARPOB Growth Targeted: Average revenue per occupied bed (ARPOB) is guided to grow 8–10% annually, with new facilities expected to lift group averages.
